Monday 12 September 2016, Amsterdam
The report, now available on ASDReports, "Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, & S-ICD) and External (Manual, AED, & Wearable)), & End User (Hospital, Prehospital, Public Access, & Home) - Global Forecasts to 2021", The global defibrillators market is expected to reach USD 14.21 Billion by 2021 from USD 10.01 Billion in 2016, at a CAGR of 7.3% between 2016 and 2021.
The development of technologically advanced defibrillators, rapid growth in the aging population with high risk of target diseases, rising incidences of cardiovascular diseases across the globe, growing focus of public and private organizations and key market players toward public access defibrillation, and increasing number of training and awareness programs across the globe will majorly drive the defibrillators market.
This report broadly segments the global defibrillators market on the basis of products and end users. By products, the defibrillators market is segmented into implantable cardioverter defibrillators (ICDs) and external defibrillators. The ICDs segment is further divided into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs). The T-ICDs segment is further classified into single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy defibrillators (CRT-Ds). The external defibrillators segment is categorized into manual external defibrillators, automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs). The AEDs segment is further divided into semi-automated external defibrillators and fully automated external defibrillators.
On the basis of end users, the defibrillators market is divided into five major segments, namely, hospitals, clinics, & cardiac centers; prehospitals; public access markets; alternate care markets; and home care. The hospitals, clinics, & cardiac centers segment is expected to account for the largest share of the defibrillators market in 2016. However, the public access markets segment is expected to grow at the highest CAGR in the next five years.
This report covers the defibrillators market across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to hold the largest share of this market in 2016, while Asia-Pacific is expected to grow at the highest rate during the forecast period from 2016 to 2021. Improving healthcare infrastructure, favorable government initiatives in the Asia-Pacific region, increasing incidences of cardiovascular diseases, and growing focus of market players are expected to drive the defibrillators market in this region.
Medtronic PLC (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), LivaNova PLC (U.K.), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), Cardiac Science Corporation (U.S.), Physio-Control, Inc. (U.S.), and Nihon Kohden Corporation (Japan) are the key players in the global defibrillators market.
ASDReports.com Media contact: S. Koopman -
Marketing and Communications
ASDReports.com / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216 - E : email@example.com
back to News